Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_provenance.
- NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_assertion description "[Furthermore, high S-phase kinase-associated protein 2 immunoreactivity was found to be significantly correlated with reduced expression of P27, P21, and cell-cycle checkpoint kinase 2, as well as with increased expression of transcription factors Dp-1, cyclin D2, and cyclin D1 in hepatocellular carcinoma tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_provenance.
- NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_assertion evidence source_evidence_literature NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_provenance.
- NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_assertion SIO_000772 22204716 NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_provenance.
- NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_assertion wasDerivedFrom befree-20140225 NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_provenance.
- NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_assertion wasGeneratedBy ECO_0000203 NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP364979.RA6zPd-HYiZUmBYfQri_yz3W3B2-dlucbP6_TdcUVC9DI130_provenance.